Search

everythinglearnresearchcommunity

for

Search:↓

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

Activating Nrf2 in skin cells speeds up wound healing by increasing the growth of certain stem cells.

Some lung cancer patients treated with EGFR inhibitors may develop a hair loss condition similar to folliculitis decalvans.

The conclusion is that androgenetic alopecia and senescent alopecia have unique gene changes, suggesting different causes and potential treatments for these hair loss types.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

The nude gene causes skin cell overgrowth and improper development, leading to hair and urinary issues.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Certain genes are more active in baby scalp cells and can help grow hair when added to adult mouse skin cells.

SA linked to mitochondrial issues and oxidative stress, while AGA involves disrupted hair growth genes.

Researchers found four genes that could help diagnose severe alopecia areata early.

Melatonin affects cashmere growth in goats by influencing stem cell and certain signaling pathways.

Genetic mutations cause various hair diseases, and whole genome sequencing may reveal more about these conditions.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

Key genes linked to immune response are highly active in lupus-affected hair follicles.

Dr. Mario Lacouture recommends preventive and specific treatments for skin side effects caused by EGFR inhibitors to improve patients' quality of life.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Hair, teeth, and mammary glands develop similarly at first but use different genes later.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

The research provides a gene-based framework for hair biology, highlighting the Hippo pathway's importance and suggesting links between hair disorders, cancer pathways, and the immune system.

UV photography can help identify people at higher risk for skin cancer, and male pattern baldness at age 45 is linked to a higher risk of certain skin cancers.

The visfatin GT genotype may increase the risk of Alopecia Areata.

New insights into cell communication in psoriasis suggest innovative drug treatments.

Differences in growth factors in platelet-rich plasma therapy for hair loss can vary between patients and can be influenced by the devices used, possibly leading to inconsistent results.

Different types of skin stem cells can change and adapt, which is important for developing new treatments.

Many patients on new leukemia drugs had mild to moderate skin reactions.

The symposium highlighted the importance of understanding disease mechanisms for targeted dermatology treatments.

TCDD speeds up skin barrier formation by increasing certain gene expressions.

A blood pressure drug, diltiazem, may also help treat influenza.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.